3rd Circuit: Janssen Didn’t Show Irreparable Harm From Patent Settlement Breach
PHILADELPHIA — A Third Circuit U.S. Court of Appeals panel affirmed a New Jersey federal judge’s denial of a preliminary injunction requested by appellants Johnson & Johnson and Janssen Biotech Inc.,...To view the full article, register now.
Already a subscriber? Click here to view full article